NASDAQ · IBB

iShares Biotechnology ETF (IBB)

$213.43−2.16%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$213.43▲ 29.38% in range
Nov 12, 2025Low $160.41 · High $221.13Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026

iShares Biotechnology ETF closed at $213.43 on Nov 12, down 2.16%, 3.5% below its 52-week closing high. Volume of 2.6M shares was 1.31× its 20-day average (above normal).

Split-adjusted performance: +5.0% over one month, +24.6% over six months, +30.0% over one year.

Short interest was 10.1M shares at the Oct 30 settlement, down 13.1% from the prior report (5.7 days to cover).

Market cap$11.13B52.1M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.02%$0.0112 last paid
52-week range160.41 – 221.13−3.5% from high
Volume2.6M1.31× 20-day avg
Volatility · 60d26.6%Annualised
Short % of float—5.7 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.6%1M +5.0%3M +7.7%6M +24.6%YTD +26.5%1Y +30.0%3Y +77.4%5Y +31.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short10.1M−13.1% vs prior
Days to cover5.7Settled Oct 30
% of float—
Short vol. 10d63.3%of daily volume

Quick answers

What is IBB's market cap?
$11.13B, based on the Nov 12 close of $213.43.
Does iShares Biotechnology ETF pay a dividend?
Yes. The latest regular dividend was $0.0112 per share (ex-date Sep 15), an annualised yield of 0.02%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology